Skip to main content

Advertisement

Log in

Gastrointestinal signet ring cell malignancy: current advancement and future prospects

  • Review
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Abstract

Globally, gastrointestinal cancer is the most widespread neoplastic disease and the primary contributor to cancer-associated fatalities. Gastrointestinal signet ring cell carcinoma (SRCC) exhibits unique distinguishing features in several aspects when compared to adenocarcinomas (ACs). The scarcity of signet ring cell carcinoma has resulted in a heightened significance of related clinical and molecular investigations. However, a comprehensive and systematic review of the clinical, molecular, therapeutic, and research aspects of this disease is currently absent. This review provides an overview of the latest developments in our understanding of the clinical and molecular features of gastrointestinal signet ring cell carcinoma (SRCC). Additionally, we have compiled a list of potential therapeutic targets or biomarkers, as well as an examination of the current treatment options and the possible mechanisms of formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

All data generated or analysed during this study are included in this published article.

Abbreviations

SRCC:

Signet ring cell adenocarcinomas

CMT:

Combined modality therapy

GC:

Gastric cancer

CRC:

Colorectal cancer

AC:

Conventional adenocarcinoma

MAC:

Mucinous adenocarcinoma

G-SRCC:

Gastric SRC carcinoma

IGCA:

International Gastric Cancer Association

PC:

Poorly cohesive

WMD:

Well-to-moderately differentiated

NSRCC:

Non-SRC

CRC:

Colorectal cancer

CR-SRCC:

Signet ring cell colorectal cancer

ctDNA:

Circular tumour DNA

MRD:

Molecular residual disease

References

  1. Laufman H, Saphir O (1951) Primary linitis plastica type of carcinoma of the colon. AMA Arch Surg 62:79–91. https://doi.org/10.1001/archsurg.1951.01250030082009

    Article  CAS  PubMed  Google Scholar 

  2. Saphir O (1955) Signet-ring cell carcinoma of the urinary bladder. Am J Pathol 31:223–231

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Nagtegaal ID, Odze RD, Klimstra D et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182–188. https://doi.org/10.1111/his.13975

    Article  PubMed  Google Scholar 

  4. Benesch MGK, Mathieson A (2020) Epidemiology of Signet Ring Cell Adenocarcinomas. Cancers (Basel) 12. https://doi.org/10.3390/cancers12061544

  5. Shi T, Song X, Liu Q et al (2019) Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: a large population-based study. Cancer Med 8:6010–6020. https://doi.org/10.1002/cam4.2521

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Leopoldo S, Lorena B, Cinzia A et al (2008) Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Ann Surg Oncol 15:1429–1439. https://doi.org/10.1245/s10434-007-9757-1

    Article  PubMed  Google Scholar 

  7. Börger ME, Gosens MJ, Jeuken JW et al (2007) Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol 212:278–286. https://doi.org/10.1002/path.2181

    Article  CAS  PubMed  Google Scholar 

  8. Nitsche U, Zimmermann A, Späth C et al (2013) Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in Tumor biology and prognosis. Ann Surg 258 775 – 82; discussion 782-3. https://doi.org/10.1097/SLA.0b013e3182a69f7e

  9. Enlow JM, Denlinger CE, Stroud MR et al (2013) Adenocarcinoma of the esophagus with signet ring cell features portends a poor prognosis. Ann Thorac Surg 96:1927–1932. https://doi.org/10.1016/j.athoracsur.2013.06.047

    Article  PubMed  Google Scholar 

  10. Wang T, Shen B, Wang L, Liu F (2020) Primary signet ring cell carcinoma of the breast: a rare entity with unique biological behavior-A clinical study based on pure signet ring cell carcinoma cohort. Pathol Res Pract 216:152948. https://doi.org/10.1016/j.prp.2020.152948

    Article  PubMed  Google Scholar 

  11. Taghavi S, Jayarajan SN, Davey A, Willis AI (2012) Prognostic significance of signet ring gastric cancer. J Clin Oncol 30:3493–3498. https://doi.org/10.1200/JCO.2012.42.6635

    Article  PubMed  PubMed Central  Google Scholar 

  12. Zhao B, Lu H, Luo R et al (2021) Different clinicopathologic features and prognostic significance of signet ring cell histology in early and locally advanced gastric cancer patients. Clin Res Hepatol Gastroenterol 45:101454. https://doi.org/10.1016/j.clinre.2020.05.006

    Article  PubMed  Google Scholar 

  13. Kwon KJ, Shim KN, Song EM et al (2014) Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach. Gastric Cancer 17:43–53. https://doi.org/10.1007/s10120-013-0234-1

    Article  PubMed  Google Scholar 

  14. Pernot S, Voron T, Perkins G et al (2015) Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol 21:11428–11438. https://doi.org/10.3748/wjg.v21.i40.11428

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Chew MH, Yeo SA, Ng ZP et al (2010) Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers. Int J Colorectal Dis 25:1221–1229. https://doi.org/10.1007/s00384-010-1033-3

    Article  PubMed  Google Scholar 

  16. Hyngstrom JR, Hu CY, Xing Y et al (2012) Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol 19:2814–2821. https://doi.org/10.1245/s10434-012-2321-7

    Article  PubMed  PubMed Central  Google Scholar 

  17. Li C, Zheng H, Jia H et al (2019) Prognosis of three histological subtypes of colorectal adenocarcinoma: a retrospective analysis of 8005 Chinese patients. Cancer Med 8:3411–3419. https://doi.org/10.1002/cam4.2234

    Article  PubMed  PubMed Central  Google Scholar 

  18. Luo C, Cen S, Ding G, Wu W (2019) Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun (Lond) 39:13. https://doi.org/10.1186/s40880-019-0361-0

    Article  PubMed  Google Scholar 

  19. Fan Y, Bai B, Liang Y et al (2021) Proteomic profiling of gastric Signet Ring Cell Carcinoma tissues reveals characteristic changes of the complement Cascade Pathway. Mol Cell Proteomics 20:100068. https://doi.org/10.1016/j.mcpro.2021.100068

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kim H, Kim BH, Lee D, Shin E (2019) Genomic alterations in signet ring and mucinous patterned colorectal carcinoma. Pathol Res Pract 215:152566. https://doi.org/10.1016/j.prp.2019.152566

    Article  CAS  PubMed  Google Scholar 

  21. Arai T (2019) Where does signet-ring cell carcinoma come from and where does it go? Gastric Cancer 22:651–652. https://doi.org/10.1007/s10120-019-00960-w

    Article  PubMed  Google Scholar 

  22. Mariette C, Carneiro F, Grabsch HI et al (2019) Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer 22:1–9. https://doi.org/10.1007/s10120-018-0868-0

    Article  CAS  PubMed  Google Scholar 

  23. Monster JL, Kemp LJS, Gloerich M, van der Post RS (2022) Diffuse gastric cancer: emerging mechanisms of Tumor initiation and progression. Biochim Biophys Acta Rev Cancer 1877:188719. https://doi.org/10.1016/j.bbcan.2022.188719

    Article  CAS  PubMed  Google Scholar 

  24. Chen J, Cai R, Ren G et al (2018) Differences in clinicopathological characteristics and computed tomography findings between signet ring cell carcinoma and nonsignet ring cell carcinoma in early and advanced gastric cancer. Cancer Med 7:1160–1169. https://doi.org/10.1002/cam4.1417

    Article  PubMed  PubMed Central  Google Scholar 

  25. Drubay V, Nuytens F, Renaud F et al (2022) Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: updated review of definition, classification and therapeutic management. World J Gastrointest Oncol 14:1406–1428. https://doi.org/10.4251/wjgo.v14.i8.1406

    Article  PubMed  PubMed Central  Google Scholar 

  26. Bae GE, Kang SH, Kim JS et al (2022) Characterization of poorly cohesive and Signet Ring Cell Carcinomas and Identification of PTPRM as a diagnostic marker. Cancers (Basel) 14. https://doi.org/10.3390/cancers14102502

  27. Chen Y, Zhou Q, Wang H et al (2020) Predicting Peritoneal dissemination of gastric Cancer in the era of Precision Medicine: molecular characterization and biomarkers. Cancers (Basel) 12. https://doi.org/10.3390/cancers12082236

  28. Chen TH, Lin WR, Lee C et al (2018) Prognostic stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological factors and GALNT14 genotype. J Cancer 9:3540–3547. https://doi.org/10.7150/jca.26293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Chon HJ, Hyung WJ, Kim C et al (2017) Differential Prognostic implications of gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis from a single high-volume Center in Asia. Ann Surg 265:946–953. https://doi.org/10.1097/SLA.0000000000001793

    Article  PubMed  Google Scholar 

  30. Liu X, Cai H, Sheng W et al (2015) Clinicopathological Characteristics and Survival Outcomes of Primary Signet Ring Cell Carcinoma in the stomach: retrospective analysis of single Center Database. PLoS ONE 10:e0144420. https://doi.org/10.1371/journal.pone.0144420

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Xu J, Sun Z, Ju H et al (2022) Construction of Novel Prognostic Nomogram for Mucinous and Signet Ring Cell Colorectal Cancer patients with a survival longer than 5 years. Int J Gen Med 15:2549–2573. https://doi.org/10.2147/ijgm.S353523

    Article  PubMed  PubMed Central  Google Scholar 

  32. Korphaisarn K, Morris V, Davis JS et al (2019) Signet ring cell Colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma. Br J Cancer 121:505–510. https://doi.org/10.1038/s41416-019-0548-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Holowatyj AN, Lewis MA, Pannier ST et al (2019) Clinicopathologic and Racial/Ethnic differences of Colorectal Cancer among adolescents and Young adults. Clin Transl Gastroenterol 10:e00059. https://doi.org/10.14309/ctg.0000000000000059

    Article  PubMed  PubMed Central  Google Scholar 

  34. Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

    Article  PubMed  Google Scholar 

  35. Siegel RL, Torre LA, Soerjomataram I et al (2019) Global patterns and trends in Colorectal cancer incidence in young adults. Gut 68:2179–2185. https://doi.org/10.1136/gutjnl-2019-319511

    Article  PubMed  Google Scholar 

  36. Chen JS, Hsieh PS, Hung SY et al (2004) Clinical significance of signet ring cell rectal carcinoma. Int J Colorectal Dis 19:102–107. https://doi.org/10.1007/s00384-003-0515-y

    Article  PubMed  Google Scholar 

  37. Zhu L, Ling C, Xu T et al (2021) Clinicopathological features and survival of Signet-Ring Cell Carcinoma and Mucinous Adenocarcinoma of Right Colon, left Colon, and Rectum. Pathol Oncol Res 27:1609800. https://doi.org/10.3389/pore.2021.1609800

    Article  PubMed  PubMed Central  Google Scholar 

  38. Yokoyama A, Shi BH, Kawai T et al (2007) Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines. Biochem Biophys Res Commun 355:200–203. https://doi.org/10.1016/j.bbrc.2007.01.133

    Article  CAS  PubMed  Google Scholar 

  39. Xu Q, Karouji Y, Kobayashi M et al (2003) The PI 3-kinase-Rac-p38 MAP kinase pathway is involved in the formation of signet-ring cell carcinoma. Oncogene 22:5537–5544. https://doi.org/10.1038/sj.onc.1206796

    Article  CAS  PubMed  Google Scholar 

  40. Fukui Y (2014) Mechanisms behind signet ring cell carcinoma formation. Biochem Biophys Res Commun 450:1231–1233. https://doi.org/10.1016/j.bbrc.2014.07.025

    Article  CAS  PubMed  Google Scholar 

  41. Ma YR, Ren Z, Conner MG et al (2017) Reduced E-Cadherin and aberrant β-Catenin expression are Associated with Advanced Disease in Signet-Ring Cell Carcinomas. Appl Immunohistochem Mol Morphol 25:432–438. https://doi.org/10.1097/pai.0000000000000317

    Article  CAS  PubMed  Google Scholar 

  42. Liu J, Xiao Q, Xiao J et al (2022) Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 7:3. https://doi.org/10.1038/s41392-021-00762-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Togasaki K, Sugimoto S, Ohta Y et al (2021) Wnt signaling shapes the histologic variation in diffuse gastric Cancer. Gastroenterology 160:823–830. https://doi.org/10.1053/j.gastro.2020.10.047

    Article  CAS  PubMed  Google Scholar 

  44. Li Y, Li J, Wang R et al (2020) Frequent RNF43 mutation contributes to moderate activation of wnt signaling in colorectal signet-ring cell carcinoma. Protein Cell 11:292–298. https://doi.org/10.1007/s13238-020-00691-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Ahadi M, Sokolova A, Brown I et al (2021) The 2019 World Health Organization classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment. Pathology 53:454–461. https://doi.org/10.1016/j.pathol.2020.10.010

    Article  PubMed  Google Scholar 

  46. Shu Y, Zhang W, Hou Q et al (2018) Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer. Nat Commun 9:2447. https://doi.org/10.1038/s41467-018-04907-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Puccini A, Poorman K, Catalano F et al (2022) Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets. Oncogene 41:3455–3460. https://doi.org/10.1038/s41388-022-02350-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Jin S, Xu B, Yu L et al (2017) The PD-1, PD-L1 expression and CD3 + T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy. Oncotarget 8:38850–38862. https://doi.org/10.18632/oncotarget.16407

    Article  PubMed  PubMed Central  Google Scholar 

  49. Nam JY, Oh BY, Hong HK et al (2018) Molecular characterization of Colorectal Signet-Ring Cell Carcinoma using whole-exome and RNA sequencing. Transl Oncol 11:836–844. https://doi.org/10.1016/j.tranon.2018.04.007

    Article  PubMed  PubMed Central  Google Scholar 

  50. Alvi MA, Loughrey MB, Dunne P et al (2017) Molecular profiling of signet ring cell Colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies. Br J Cancer 117:203–209. https://doi.org/10.1038/bjc.2017.168

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Roy S, Kanda M, Nomura S et al (2022) Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer. Mol Cancer 21:42. https://doi.org/10.1186/s12943-022-01527-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Patel SG, Karlitz JJ, Yen T et al (2022) The rising tide of early-onset Colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol 7:262–274. https://doi.org/10.1016/s2468-1253(21)00426-x

    Article  PubMed  Google Scholar 

  53. Luo H, Zhao Q, Wei W et al (2020) Circulating Tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for Colorectal cancer. Sci Transl Med 12. https://doi.org/10.1126/scitranslmed.aax7533

  54. Kumar NAN, Jose A, Usman N et al (2022) Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges. Langenbecks Arch Surg 407:87–98. https://doi.org/10.1007/s00423-021-02314-6

    Article  PubMed  Google Scholar 

  55. Shi T, Huang M, Han D et al (2019) Chemotherapy is associated with increased survival from colorectal signet ring cell carcinoma with distant Metastasis: a Surveillance, Epidemiology, and end results database analysis. Cancer Med 8:1930–1940. https://doi.org/10.1002/cam4.2054

    Article  PubMed  PubMed Central  Google Scholar 

  56. Parikh AR, Van Seventer EE, Siravegna G et al (2021) Minimal residual Disease detection using a plasma-only circulating Tumor DNA assay in patients with Colorectal Cancer. Clin Cancer Res 27:5586–5594. https://doi.org/10.1158/1078-0432.Ccr-21-0410

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Dr. Wanglong Deng, Dr. Guanghua Lu, Mr. Ran Ding from Jiangsu Simcere Diagnostics for their kind assistance.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

Author ContributionsConception/design: D.W, WP.H; Provision of study material or patients: QJ.H, Y.T, QQ. D, Q.Z; Collection and/or assembly of data: C.Q, DS.C Data analysis and interpretation: All authors. Manuscript writing: D.W, WP.H Final approval of manuscript: All authors.

Corresponding author

Correspondence to Da Wang.

Ethics declarations

Conflicts of interest

The authors have no conflict of interest.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hong, W., Hu, Q., Tan, Y. et al. Gastrointestinal signet ring cell malignancy: current advancement and future prospects. Invest New Drugs 41, 861–869 (2023). https://doi.org/10.1007/s10637-023-01403-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-023-01403-1

Keywords

Navigation